The Blubber

Nvidia, $NVDA, has disclosed investments in Arm Holdings, $ARM, SoundHound AI, $SOUN, and the biotech company Recursion Pharmaceuticals, $RXRX.


Nvidia Corp., a key player in the AI sector, revealed investments in Arm Holdings Plc, SoundHound AI Inc., and the biotech firm Recursion Pharmaceuticals Inc. in a 13F form filed with the US Securities and Exchange Commission on Wednesday. This filing offers insight into the company's investment strategy. Nvidia has a history with Arm, having made a failed attempt to acquire it for $40 billion in 2020, a deal that fell apart due to regulatory pressures, leading Nvidia to abandon it in February 2022.

The investment in SoundHound was seen as a positive move by investors in that company, as its shares surged by as much as 55% in after-hours trading on Wednesday following the disclosure of Nvidia's stake. SoundHound specializes in AI software for audio recognition, and Nvidia has been involved with the company since investing in 2017.

In terms of dollar value, the largest investment was in Arm, amounting to $147.3 million. The investment in Recursion was valued at $76 million, while the stake in SoundHound was $3.67 million. Nvidia also disclosed smaller investments in medical imaging developer Nano-X Imaging Ltd. and the self-driving company TuSimple Holdings Inc.

Since the failed acquisition by Nvidia, Arm has become the largest IPO of 2023. It remains predominantly owned by SoftBank Group Corp., which acquired the chip designer in 2016 for $32 billion. SoftBank has seen significant gains from the surge in Arm shares, which have risen by more than two-thirds this year, pushing its market valuation to nearly $130 billion.